Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Key Laboratory of Dairy Products Processing, Ministry of Agriculture, Inner Mongolia Agricultural University, Huhhot 010018, China
Auto-generated profile, based on publicly available information
Xiaoye Bai
Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Key Laboratory of Dairy Products Processing, Ministry of Agriculture, Inner Mongolia Agricultural University, Huhhot 010018, China
Studies suggest that probiotics and fermented milk can improve defecation in constipated patients. However, the mechanism of fermented milk containing probiotics on constipation remains poorly understood. Volunteers with chronic constipation symptoms were recruited and given 200 g/d of fermented milk containing Lactobacillus casei Zhang and Bifidobacterium animalis ssp. lactis V9 (PFM) for 4 wk. Clinical symptoms, cytokines, metagenomics, and metabolomics were evaluated in constipated participants before and after PFM intervention. After PFM intervention, we observed significant improvement of constipation symptoms. In the serum samples, the anti-inflammatory cytokine IL-10 increased and the proinflammatory cytokine C-reactive protein and lipopolysaccharides decreased. Metagenomics results showed that the increase of B. animalis was correlated with an increase in defecation frequency. Fatty acid biosynthesis and bile acid biosynthesis in stool samples as well as carnitine shuttle, vitamin E metabolism, and ascorbate and aldarate metabolism were identified as significantly altered metabolic pathways. Acylcarnitine, located on the carnitine shuttle pathway, had a significantly positive correlation with defecation frequency. It was speculated that PFM may contribute to alleviating constipation symptoms through 3 potential mechanisms: fine-tuning gastrointestinal microbiota, fighting inflammation, and regulating metabolic pathways.
Background : Bifidobacteria were poorly represented or even totally absent in many of the currently published microbiota/metagenomics datasets. This work designed Bifidobacterium -targeting primers that were suitable for use in high-throughput sequencing to characterized the feature of Bifidobacterium . Results : After multiple steps of in silico prediction, phylogenetic analysis, polymerase chain reaction and single-molecule real-time sequencing (SMRT) experiments, the Bif-6 primer pair was confirmed to be optimal for such purpose. Up to 99.42% and 99.32% of the detected sequences in human stool and breast milk samples represented up to 6 and 8 different Bifidobacterium species, respectively. Additionally, the Bif-6 primer pair detected the species Bifidobacterium catenulatum and Bifidobacterium kashiwanohense , which have not previously been reported in human breast milk to our knowledge. The high specificity of Bif-6 could be explained by the lower average nucleotide identity of 78.42% (versus 93.91% for the universal primers 27f/1492r). Moreover, to optimize the process of microbiota annotation, here a Bifidobacterium -specific database was constructed that largely reduced the time required for annotation compared with using the NCBI nucleotide (nt) database. The two databases generated highly consistent profiles of bifidobacteria when tested on the same samples. Conclusion : this work designed a highly reliable primer and database specific for detecting the bifidobacterial population in complex biological samples, which will facilitate future studies of this group of bacteria.